ICV Value = 72.57
ISSN: 2643-6051
Research and Reviews of Infectious Diseases is an open access, peer reviewed journal publishes high quality manuscripts focusing prevention, diagnosis and treatment of disorders caused by organisms such as bacteria, viruses, fungi or parasites. The journal focus upon gathering disease types, causes, prevention, and treatment, and helps learn how they spread. The journal aims to bring multiple internationally peer reviewed experts under one roof thereby encouraging knowledge sharing, collaboration and promotion of multidisciplinary science.
All the published content is permitted to use under Creative Common Attribution License. The journal publishes topics ranging from clinical descriptions of infections, epidemics, pandemics, outbreak of contagious diseases, public health, microbiology, and immunology to the prevention of infection, the evaluation of current and novel treatments, and the promotion of optimal practices for diagnosis and treatment.
The journal invites original research, review articles, case reports, case series, short communications, opinions, short note and perspectives in the field of infectious diseases.
Professor
Boonshoft School of Medicine
Wright State University
United States of America
Tel: 937-760-7205
Professor
Department of Biology
The University of Texas at San Antonio
United States of America
Tel: 210-458-5663
Director and Associate Profressor
Department of Internal Medicine
Albert Einstein College of Medicine
New York
United States of America
Professor and Director Haskins Laboratories
Pace University
New York
United States of America
Tel: 212-346-1853
Professor
Department of Mathematics
Konkuk University
South Korea
Tel: 010-9973-4163
Professor
Department of Biological Science
Sungkyunkwan University
Suwon City, Korea
Tel: +82-31-290-7002
Submit your manuscript to this journal through online or email us at editorialoffice@scholars.direct
Case Study
Effective Treatment against SARS-Cov-2 with Amantadine Hydrochloride
Based on 100 documented cases treated with amantadine, we suggest that with this method of treatment, at least 90% of severe cases in Poland (or even ... Read more
Research Article
It is shown that in the conditions of the metropolis young age, early sexual life, the presence of premarital sexual experience, as well as a low leve... Read more
Mini Review
Coronavirus disease (COVID-19) pandemic currently 189.921.964 confirmed cases world wide; 4.088.281 continues with the case resulting in death. SARS-C... Read more
Review Article
Quality of Life for Patients Recovered from Covid-19
86 patients were included (70.9% women and 29.1% men), mean age 37.69. COVID-19 infection begins an average of 12.2 weeks after clinical recovery. Acc... Read more
Case Report
Respiratory disorders are at the fore front of severe COVID-19 disease and can lead to acute respiratory distress syndrome (ARDS). This article provid... Read more
Retrospective Study
The pathogenesis of novel coronavirus disease (COVID-19) includes virus-induced systemic endothelial dysfunction, cytokine storm, and complement casca... Read more
Commentary
Post-COVID Geriatric Patients - Anaesthetic Considerations
Such headings often greet us in newspapers and news channels during coronavirus disease (COVID) times. This only means that there are quite a few geri... Read more
Review Article
Group B Streptococcus (GBS) is an important perinatal pathogen. It is considered as a leading cause of stillbirth and early onset neonatal in... Read more
Review Article
Clinical Aspects of COVID-19 in Patients with Solid Organ Transplantation: A Systematic Review
Coronavirus disease 19 (COVID-19), is an infectious disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This virus is ... Read more
Case Report
Protective Effect of Amantadine in a COVID-19 Patient: Case Report
In the recent bibliography are few clinical cases related the hypothetic role as preventive use of amantadine, Aranda presents a 57-year-old man with ... Read more
